Interacting Drugs |
Ofloxacin (systemic) vs Bendamustine |
Security Level |
|
Mechanism |
Bendamustine: CYP1A2 Inhibitors (Strong) may increase the serum concentration of Bendamustine. Concentrations of the active metabolites of bendamustine may be decreased. |
Management |
Monitor therapy |
Ofloxacin (systemic) vs Bendamustine
Post Review about Ofloxacin (systemic) vs Bendamustine Click here to cancel reply.
Other Interactions of Ofloxacin (systemic)
Other Interactions of Bendamustine
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.